SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-199894
Filing Date
2017-06-09
Accepted
2017-06-09 15:58:23
Documents
4
Period of Report
2017-07-06
Effectiveness Date
2017-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A d514127ddef14a.htm DEF 14A 278061
2 GRAPHIC g514127img01.jpg GRAPHIC 287793
3 GRAPHIC g514127img02.jpg GRAPHIC 159701
4 GRAPHIC g514127snap0001.jpg GRAPHIC 5487
  Complete submission text file 0001193125-17-199894.txt   903706
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33958 | Film No.: 17902836
SIC: 2834 Pharmaceutical Preparations